United Therapeutics (UTHR) Research & Development (2009 - 2026)
United Therapeutics (UTHR) posted Research & Development of $146.3 million for Q2 2026, up 9.2% from $134 million a year earlier and up 5.9% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at United Therapeutics was $551.5 million, up 6.0% year-over-year; for FY2025, it came in at $550 million, up 14.3% from FY2024.
- Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 9.0% (FY2020 to FY2025).
- In prior years, United Therapeutics' Research & Development was $481 million in FY2024 (+17.9%), $408 million in FY2023 (+26.4%), $322.9 million in FY2022 (-40.2%) and $540.1 million in FY2021 (+51.0%).
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q1 2025.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 9.9%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 61.2%; the weakest was Q1 2022, with a decline of 77.3%.
- According to Business Quant data, Research & Development for the three prior quarters was $138.2 million (Q1 2026), $139.5 million (Q4 2025) and $127.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | United Therapeutics | 25.03 Bn | 15.22 Bn | 733.40 Mn | 279.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 279.20 Mn |
| Jun 30, 2026 | 146.30 Mn |
| Mar 31, 2026 | 138.20 Mn |
| Dec 31, 2025 | 139.50 Mn |
| Sep 30, 2025 | 127.50 Mn |
| Jun 30, 2025 | 134.00 Mn |
| Mar 31, 2025 | 149.00 Mn |
| Dec 31, 2024 | 133.80 Mn |
| Sep 30, 2024 | 103.50 Mn |
| Jun 30, 2024 | 139.60 Mn |
| Mar 31, 2024 | 104.10 Mn |
| Dec 31, 2023 | 151.40 Mn |
| Sep 30, 2023 | 84.70 Mn |
| Jun 30, 2023 | 89.00 Mn |
| Mar 31, 2023 | 82.90 Mn |
| Dec 31, 2022 | 93.90 Mn |
| Sep 30, 2022 | 66.10 Mn |
| Jun 30, 2022 | 93.90 Mn |
| Mar 31, 2022 | 69.00 Mn |
| Dec 31, 2021 | 82.90 Mn |
API Access
United Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();